Life sciences startup Unchained Labs grabs $25 mln

Pleasanton, California-based life sciences tools startup Unchained Labs has closed $25 million in Series A funding. Novo Ventures, Canaan Partners and TPG Biotech led the round. Also, the company has acquired Optim, a multiplex protein stability platform for biologics. No financial terms were disclosed.

13 February 2015•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail